Avantax Planning Partners’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10	Closed	-$9K	–	877
2018 Q3	$9K	Buy	+10	New	+$9K	﹤0.01%	914
2018 Q2	–	Sell	-6	Closed	-$10K	–	1026
2018 Q1	$10K	Buy	+6	New	+$10K	﹤0.01%	1055